Self-peptides bound to HLA molecules.

P E Harris

Home/Archive/PubMed

PubMed · 7741977

Self-peptides bound to HLA molecules.

P E Harris

View original source ↗Export metadata ↓

Abstract

The characterization of peptide bound to major histocompatibility complex (MHC) molecules has yielded insight to certain functional aspects of MHC molecules, the effects of MHC polymorphism, and the mechanism of antigen processing and presentation. The self-peptides bound to over 20 different human MHC molecules have been structurally analyzed, and they reveal information that complements our understanding of the three-dimensional structure of MHC molecules established by X-ray crystallography. Sequence analysis of individual self-peptides and the identification of their precursor proteins reveal the cellular geography of antigen processing and lays the foundation for advanced study of tolerance, autoimmunity, and anti-tumor immunity.

Explore related subjects

HLA Antigens Humans Peptides Receptors, Antigen, T-Cell, alpha-beta Receptors, Antigen, T-Cell, gamma-delta Self Tolerance Journal Article Review

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

P E Harris. 1994. Self-peptides bound to HLA molecules.. https://pubmed.ncbi.nlm.nih.gov/7741977/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Soluble HLA revisited.

The goal of this editorial is to revisit soluble human leukocyte antigens (sHLA) and to highlight the findings reported by Albitar et al. in this issue on the relation between sHLA levels in Non-Hodgkin's Lymphoma (NHL) and Hodgkin's Disease (HD). We will review key aspects of sHLA including soluble HLA-G, which has received a lot of attention in recent publications. We will then address the role of sHLA in lymphoproliferative diseases and in solid organ tumors. Lastly, we will comment on the results of Albitar et al. and their relevance to clinical application in NHL.

HLA Antigens↗

PubMed2006

Nomenclature for factors of the HLA system, update July 2005.

Explore the source record for details and available documents.

HLA Antigens↗

PubMed2006

Impact of KIR/HLA ligand combinations on immune responses in malignant melanoma.

Tumor growth and dissemination depend partly on the reactivity of natural killer (NK) cells and T cells expressing NK-associated receptors. Their effector functions are regulated by an array of activating and inhibitory cell surface receptors with MHC class I ligand specificity, such as the killer immunoglobulin-like receptors (KIRs). Given the extensive genomic diversity of KIRs and their HLA ligands, it is reasonable to speculate that HLA, KIR gene variations and specific KIR-ligand combinations will have an impact on disease susceptibility and/or progression. Here, we discuss how KIR genotypes and KIR/HLA immunogenetic profiles may be involved in tumorigenesis, especially in malignant melanoma (MM). A hypothetical model of the impact of KIR/ligand combinations on immune responses in MM is proposed.

HLA Antigens↗